Chase Investment Counsel Corp Merck & Co., Inc. Transaction History

Chase Investment Counsel Corp

$262 Million
Q1 2024

A detailed history of Chase Investment Counsel Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Chase Investment Counsel Corp holds 8,360 shares of MRK stock, worth $1.06 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

8,360

Previous 8,101 3.2%

Holding current value

$1.06 Million

Previous $883,000 24.92%

% of portfolio

0.42%

Previous 0.39%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$113.24 - $131.95 $29,329 - $34,175	259 Added 3.2%	8,360 $1.1 Million
Q4 2023 Feb 05, 2024	SELL	$100.18 - $109.02 $562,510 - $612,147	-5,615 Reduced 40.94%	8,101 $883,000
Q3 2023 Nov 08, 2023	SELL	$102.95 - $114.33 $303,290 - $336,816	-2,946 Reduced 17.68%	13,716 $1.41 Million
Q2 2023 Jul 28, 2023	BUY	$108.61 - $118.38 $893,643 - $974,030	8,228 Added 97.56%	16,662 $1.92 Million
Q1 2023 May 04, 2023	SELL	$102.94 - $114.86 $28,308 - $31,586	-275 Reduced 3.16%	8,434 $897,000

Q4 2022 Jan 25, 2023	BUY	$87.44 - $112.11 $33,227 - $42,601	380 Added 4.56%	8,709 $966,000
Q2 2022 Jul 26, 2022	BUY	$83.49 - $94.64 $23,794 - $26,972	285 Added 3.54%	8,329 $759,000
Q1 2022 Apr 21, 2022	SELL	$73.51 - $82.4 $5,880 - $6,592	-80 Reduced 0.98%	8,044 $660,000
Q4 2021 Feb 02, 2022	BUY	$72.28 - $90.54 $14,817 - $18,560	205 Added 2.59%	8,124 $622,000
Q3 2021 Nov 04, 2021	SELL	$71.68 - $78.83 $672,716 - $739,819	-9,385 Reduced 54.24%	7,919 $594,000
Q2 2021 Jul 29, 2021	BUY	$70.31 - $77.77 $11,108 - $12,287	158 Added 0.92%	17,304 $1.35 Million
Q1 2021 May 06, 2021	BUY	$68.86 - $81.11 $6,886 - $8,111	100 Added 0.59%	17,146 $1.32 Million
Q4 2020 Feb 02, 2021	SELL	$71.77 - $79.65 $28,349 - $31,461	-395 Reduced 2.26%	17,046 $1.39 Million
Q3 2020 Nov 03, 2020	BUY	$73.18 - $82.95 $792,466 - $898,265	10,829 Added 163.78%	17,441 $1.45 Million
Q2 2020 Aug 05, 2020	BUY	$70.42 - $80.13 $81,968 - $93,271	1,164 Added 21.37%	6,612 $511,000
Q1 2020 May 08, 2020	SELL	$63.36 - $87.82 $1.8 Million - $2.5 Million	-28,432 Reduced 83.92%	5,448 $419,000
Q4 2019 Feb 06, 2020	BUY	$77.58 - $87.54 $352,135 - $397,344	4,539 Added 15.47%	33,880 $3.08 Million
Q3 2019 Oct 29, 2019	SELL	$76.08 - $82.93 $32,866 - $35,825	-432 Reduced 1.45%	29,341 $2.47 Million
Q2 2019 Aug 07, 2019	SELL	$69.84 - $81.59 $1.13 Million - $1.33 Million	-16,245 Reduced 35.3%	29,773 $2.5 Million
Q1 2019 May 03, 2019	SELL	$69.58 - $79.36 $48,497 - $55,313	-697 Reduced 1.49%	46,018 $3.83 Million
Q4 2018 Feb 04, 2019	BUY	$65.24 - $75.71 $2.66 Million - $3.09 Million	40,782 Added 687.38%	46,715 $3.57 Million
Q3 2018 Nov 01, 2018	BUY	$57.69 - $67.84 $43,959 - $51,694	762 Added 14.74%	5,933 $420,000
Q2 2018 Aug 07, 2018	BUY	$50.83 - $59.72 $4,625 - $5,434	91 Added 1.79%	5,171 $313,000
Q1 2018 May 07, 2018	BUY	$50.96 - $59.23 $258,876 - $300,888	5,080 New	5,080 $276,000

Others Institutions Holding MRK

# of Institutions

3,769

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $320B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

News

Stay updated on Chase Investment Counsel Corp with notifications on news.

Account

Chase Investment Counsel Corp Merck & Co., Inc. Transaction History